← Back to patent-cliff list
CAS 27126-93-8
3,5-bis(trifluoromethyl)benzonitrile
Codes：SELI-001
Application context (from source-drug indications)
弥漫性大B-细胞淋巴瘤塞利尼索多发性骨髓瘤塞利尼索
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| 塞利尼索Selinexor | Tier C — Watch / trade | 2030 |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
3,5-bis(trifluoromethyl)benzonitrile→3,5-bis(trifluoromethyl)benzothioamide→3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazole→isopropyl (Z)-3-iodoacrylate→isopropyl (Z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)acrylate→(Z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)acrylic acid→2-hydrazinylpyrazine
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.